Barington Capital Criticizes Victoria’s Secret (VSCO) Over Governance, Strategic Drift, and $2.4B Value Destruction

Oportun (OPRT) Faces Proxy Fight as Findell Capital Pushes Board Refresh, Nominates Warren Wilcox to Drive Oversight and Value

Findell Capital Targets Oportun (NASDAQ: OPRT) Board, Urges Shareholders to Replace CEO Vazquez for Stronger Governance

Silver Star Properties (SLVS) Faces Hartman Shareholder Alliance Push for Leadership Change After 70% Value Loss

Hartman Shareholder Alliance Blasts Silver Star Properties REIT (SLVS) Over Failed Strategy, Demands Governance Overhaul and Capital Return

Ortelius Advisors Targets Brookdale Senior Living (BKD) Board, Nominates Six Directors Amid Debt and Lease Strategy Criticism

Ortelius Advisors Presses for Board Overhaul at Brookdale Senior Living (BKD), Criticizes Debt, Leases, and Strategy in Proxy Campaign

Ikena Oncology (IKNA): BML Capital (8.4%) Opposes Inmagene Reverse Merger, Urges Winddown and Cash Return

BML Capital Opposes Ikena Oncology (IKNA)–Inmagene Merger, Urges Cash Return to Shareholders

13D weekly report - June 09, 2025 to June 13, 2025

13D weekly report - June 09, 2025 to June 13, 2025

Findell Capital (7.4% Holder) Rebuts Oportun Financial (OPRT) Claims, Pushes for Board Refresh and Independent Oversight

Findell Capital Challenges Oportun Financial (OPRT) Board, Cites Governance Failures and Urges Election of Lending Expert Warren Wilcox

Vivo Capital (8% Holder) Challenges Sinovac Biotech (SVA) Board Over Governance Failures and Dividend Misrepresentations

Vivo Capital Challenges Sinovac Biotech (SVA) Board Ahead of July 8 Vote, Citing Governance Failures and Dividend Dispute